产品介绍 评论(0)
物种
Human分子别名
CVID; CVID2; FLJ39942; MGC133214; ACIMGC39952; TNFRSF13BAccession
O14836-1表达序列
Ser2-Thr166 with His Tag at the C-terminus
表达宿主
HEK293分子量
19-22kDa (Reducing)纯度
>95% by SDS-PAGE & RP-HPLC内毒素含量
<0.1EU/μg活性
Immobilized BAFF Protein, Human (Cat. No. UA040367) at 1.0μg/mL (100μL/well) can bind TACI/CD267/TNFRSF13B His Tag Protein, Human (Cat. No. UA011174) with EC50 of 2.07-3.92ng/mL.标记
Unconjugated标签
His Tag性状
Lyophilized Powder缓冲体系
PBS, PH7.4,5% trehalose
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.文献引用
von Bulow, G.U. et al. (1997) Science, 278:138.
Marsters, S.A. et al. (2000) Curr. Biol. 10:785.
TACI (Transmembrane activator and CAML interactor) is a type III transmembrane protein and a member of the TNF receptor superfamily. It consists of an extracellular domain containing two cysteine-rich regions, a transmembrane domain, and an intracellular domain. TACI shares high homology with BCMA and binds to APRIL and BAFF, key ligands involved in immune regulation. Expressed on B cells and activated T cells, TACI plays a crucial role in B cell development and function. Its interactions with APRIL and BAFF suggest involvement in immune signaling pathways, making it a potential target for immunotherapy.
电泳
1μg (R: reducing condition, N:non-reducing condition).
ELISA
Immobilized BAFF Protein, Human (Cat. No. UA040367) at 1.0μg/mL (100μL/well) can bind TACI/CD267/TNFRSF13B His Tag Protein, Human (Cat. No. UA011174) with EC50 of 2.07-3.92ng/mL.







评论(0)